US › Healthcare

Pliant Therapeutics Inc (PLRX)

US · Healthcare · Biotechnology

$1.05+0.96%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-20.0M
Profit YoY
+64.3%
EPS
$-0.32
EPS estimate
$-0.36

EPS came in at -0.32 against a street estimate of -0.36 — a beat of 11.1%.

Key statistics

Market cap
$64.4M
Forward P/E
0.0
P/B
0.39
Book value
$2.67
EPS (TTM)
$-1.83
52-week high
$1.95
52-week low
$1.03
50-day MA
$1.15
200-day MA
$1.30
Beta
1.22

Analyst view

Analysts rate Pliant Therapeutics Inc a hold (2 buy, 11 hold, 0 sell out of 13) with an average price target of $2.50.

Shareholding

Insiders
2.23%
Institutions
82.09%

Largest institutional holders

FundStake
TANG CAPITAL MANAGEMENT LLC9.92%
Citadel Advisors Llc5.21%
Blue Owl Capital Holdings LP4.80%
ADAR1 Capital Management LLC4.17%
Acadian Asset Management LLC3.90%
Vanguard Capital Management, LLC3.78%
Two Sigma Investments LLC3.64%
Monaco Asset Management3.13%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Pliant Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.